|
Contact
Us:
For questions, comments or suggestions please contact
us.
|
|
Spotlight
Office of Public Health Genomics/CDC launches the CancerGEM KB
:
CDC Office of Public Health Genomics in collaboration with NCI Division of Cancer Control and Population Sciences launches the CancerGEM KB: CancerGEM KB is an online resource for researchers, public health professionals, policy makers, and health care providers interested in the use of genomic information in cancer care and prevention. CancerGEM KB provides objective synthesis and timely dissemination of information on cancer human genome epidemiology (genetic associations, gene-environment interactions and gene prevalence information) and aggregated evidence on cancer genomic tests in transition to clinical and public health practice. CancerGEM KB also offers summary information on Genomic Tests through PLoS Currents Evidence on Genomic Tests, an open-access journal for systematic reviews and structured short summaries of evidence for the validity and utility of genetic tests.
Read more about CancerGEM KB
|
News
related to genomic applications in cancer care and prevention
Potential Genomic Tests
recently added in
Cancer Genomic Test Finder
-
05/17/2012
:
Ovarian cancer
-
Scoring system based on expression of 23 genes involved in platinum-induced DNA repair pathways
.
See detail
-
05/17/2012
:
Cancer
-
Web-based program makes simulated pyrograms based on input such as: percentage of tumor vs normal cells, wild-type sequence, etc.; calculates relative mutant and wild-type allele percentages, generates expected signal at each point in dispensation sequence based on these data.
.
See detail
-
02/22/2012
:
Non-small cell lung cancer (NSCLC)
-
Automated immunohistochemistry (IHC)-based detection of ALK gene rearrangements (EML4-ALK translocation); test involves use of D5F3 antibody and OptiView DAB detection
.
See detail
-
02/22/2012
:
Thyroid cancer
-
Gene expression classifier following cytopathology assessment
.
See detail
-
02/22/2012
:
Lung cancer
-
14-gene expression test
.
See detail
Published Literature
recently added in
Cancer HuGE Literature Finder
-
A study of prostaglandin pathway genes and interactions with current non-steroidal anti-inflammatory drug use in colorectal adenoma.
Cancer prevention research (Philadelphia, Pa.)
2012
May
.
Edwards T, Shrubsole MJ, Cai Q, Li G, Dai Q, Rex DK, Ulbright TM, Fu Z, Murff HJ, Smalley WE, Ness RM, Zheng W
-
An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel.
Cancer chemotherapy and pharmacology
2012
May
.
Uchiyama T, Kanno H, Ishitani K, Fujii H, Ohta H, Matsui H, Kamatani N, Saito K
-
Association of IL-6 polymorphisms with gastric cancer risk: Evidences from a meta-analysis.
Cytokine
2012
May
.
Junli W, Wenjun H, Jinxin L, Legen N, Yesheng W, Fenglian Y
-
Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population.
World journal of gastroenterology : WJG
2012
May
18
(17):
17.
Wang P, Zhang L, Jiang JM, Ma D, Tao HX, Yuan SL, Wang YC, Wang LC, Liang H, Zhang ZS, Liu CJ
-
Association of variants in estrogen-related pathway genes with prostate cancer risk.
The Prostate
2012
May
.
Holt SK, Kwon EM, Fu R, Kolb S, Feng Z, Ostrander EA, Stanford JL
Published Evidence
recently added in
Cancer Evidence Aggregator
-
Garrett Dancik, Dara Aisner, Dan Theodorescu
.
A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors .
07/21/2011.
See detail
-
Naoko Ishibe, Josh Carlson, Scott David. Ramsey, Andrew Freedman, Sheri Schully
.
Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy .
07/11/2011.
See detail
-
Ralph Coates, Marc Williams, Stephanie Melillo
.
Genetic Testing for Lynch Syndrome in Individuals Newly Diagnosed with Colorectal Cancer to Reduce Morbidity and Mortality from Colorectal Cancer in Their Relatives .
07/07/2011.
See detail
-
Christine M. Nguyen, Margaret A. Mendes, Joseph D. Ma
.
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk .
05/15/2011.
See detail
-
Renée M. Ned, Stephanie Melillo, Michael Marrone
.
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure test .
03/08/2011.
See detail
|